Following the confirmation of the aptamer’s targeting capability towards MUC1-positive cells (Supplementary Fig. 9), we gauged the selectivity of A-f-M13-MB for CTC capture by incubating it with various cancer cells for 30 minutes (Fig. 6a, Supplementary Fig. 10, 11). Here, MUC1 is linked to cancer.